Michelle Priem is an accomplished professional with extensive experience in risk management and strategic planning within the biotechnology industry. Currently serving as the Director of Enterprise Risk Management at CSL Behring since September 2021, Michelle previously held various leadership roles at Amgen from 1998 to 2020, including Director of Risk Management, Director of Strategic Planning and Risk, and Risk Management Senior Manager. Michelle led significant global initiatives to reduce supply risk, establish business resilience strategies, and implement comprehensive operations risk management programs. Key achievements include the creation of the Risk Management Center of Excellence at Amgen and the successful design and execution of site-specific risk management programs. Michelle holds a Bachelor of Science degree in Psychology and Biology from Florida State University.
This person is not in any teams
This person is not in any offices